cp wire

CP Wire Articles

Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
  • The research demonstrates that specific, human microbiome-derived bacteria assembled rationally into consortia can cooperatively enhance the responses to immune checkpoint inhibitors
    • ... read more
Thu, 01/24/19 - 12:19 am
Gosssamer Bio to Use 20 Day Rule for $230 Million IPO

Gossamer Bio announced terms for it's $230 Million IPO on 1/23/19. The company plans to offer 14.4 million shares at $16 per share. Insiders have expressed an interest in acquiring $100 million of... read more

Wed, 01/23/19 - 09:14 pm
Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates

Talee Bio, Inc. announced on 1/23/19 agreements with the Cystic Fibrosis Foundation (CF Foundation) to fund the preclinical development of two mutation-agnostic gene therapy product candidates, TL... read more

Wed, 01/23/19 - 09:37 am
Microbiome Report for Week Ending 1/19/19

Seres Therapeutics Announces Chief Executive Officer Transition
Seres... read more

Wed, 01/23/19 - 09:32 am
BridgeBio Pharma Raises $299.2 Million to Support Its Genetic Disease Development Programs

BridgeBio Pharma, a clinical-stage biopharmaceutical company focused on genetic diseases, today announced a new financing round of $299.2 million. The round was co-led by existing investors KKR... read more

Wed, 01/23/19 - 09:22 am

Pages